
Christopher Upton
Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1797, 1306, 1308, 1776, 1778, 1724 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 90/006953 | TRANSFORMED MAMMALIAN CELL AND USE THEREOF FOR THE PRODUCTION OF GLYCOPROTEINS | Feb 26, 2004 | Issued |
Array
(
[id] => 7258110
[patent_doc_number] => 20040260079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Cardiac-cell specific enhancer elements and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/780120
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 10630
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20040260079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10780120
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/780120 | Cardiac-cell specific enhancer elements and uses thereof | Feb 16, 2004 | Abandoned |
Array
(
[id] => 7263935
[patent_doc_number] => 20040241856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Methods and compositions for modulating stem cells'
[patent_app_type] => new
[patent_app_number] => 10/777028
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18414
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241856.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777028
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777028 | Methods and compositions for modulating stem cells | Feb 10, 2004 | Abandoned |
Array
(
[id] => 7263483
[patent_doc_number] => 20040241714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Methods of assessment of drug metabolizing enzymes'
[patent_app_type] => new
[patent_app_number] => 10/770538
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17178
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241714.pdf
[firstpage_image] =>[orig_patent_app_number] => 10770538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/770538 | Methods of assessment of drug metabolizing enzymes | Feb 3, 2004 | Abandoned |
Array
(
[id] => 4669785
[patent_doc_number] => 20080044845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Method for Obtaining a Singular Cell Model Capable of Reproducing in Vitro the Metabolic Idiosyncrasy of Humans'
[patent_app_type] => utility
[patent_app_number] => 10/597286
[patent_app_country] => US
[patent_app_date] => 2004-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11029
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044845.pdf
[firstpage_image] =>[orig_patent_app_number] => 10597286
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/597286 | Method for Obtaining a Singular Cell Model Capable of Reproducing in Vitro the Metabolic Idiosyncrasy of Humans | Jan 18, 2004 | Abandoned |
Array
(
[id] => 4821689
[patent_doc_number] => 20080227085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Methods and Systems for the Identification of Rna Regulatory Sequences and Compounds that Modulate their Function'
[patent_app_type] => utility
[patent_app_number] => 10/542255
[patent_app_country] => US
[patent_app_date] => 2004-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15752
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227085.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542255
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542255 | Methods and Systems for the Identification of Rna Regulatory Sequences and Compounds that Modulate their Function | Jan 8, 2004 | Abandoned |
Array
(
[id] => 7677142
[patent_doc_number] => 20040152684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment'
[patent_app_type] => new
[patent_app_number] => 10/747060
[patent_app_country] => US
[patent_app_date] => 2003-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5209
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152684.pdf
[firstpage_image] =>[orig_patent_app_number] => 10747060
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/747060 | Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment | Dec 29, 2003 | Abandoned |
Array
(
[id] => 803151
[patent_doc_number] => 07422854
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-09-09
[patent_title] => 'Cholesterol reduction signature'
[patent_app_type] => utility
[patent_app_number] => 10/741509
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14628
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/422/07422854.pdf
[firstpage_image] =>[orig_patent_app_number] => 10741509
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/741509 | Cholesterol reduction signature | Dec 17, 2003 | Issued |
Array
(
[id] => 6983371
[patent_doc_number] => 20050153441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Adipose-derived stem cells and lattices'
[patent_app_type] => utility
[patent_app_number] => 10/740315
[patent_app_country] => US
[patent_app_date] => 2003-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 59812
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153441.pdf
[firstpage_image] =>[orig_patent_app_number] => 10740315
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/740315 | Adipose-derived stem cells and lattices | Dec 16, 2003 | Issued |
Array
(
[id] => 408083
[patent_doc_number] => 07285400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-23
[patent_title] => 'High bone mass gene of 11q13.3'
[patent_app_type] => utility
[patent_app_number] => 10/731739
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 36
[patent_no_of_words] => 39558
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/285/07285400.pdf
[firstpage_image] =>[orig_patent_app_number] => 10731739
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/731739 | High bone mass gene of 11q13.3 | Dec 9, 2003 | Issued |
Array
(
[id] => 6925824
[patent_doc_number] => 20050239079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Predicting outcome with tamoxifen in breast cancer'
[patent_app_type] => utility
[patent_app_number] => 10/727100
[patent_app_country] => US
[patent_app_date] => 2003-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 32199
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727100
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727100 | Predicting outcome with tamoxifen in breast cancer | Dec 1, 2003 | Issued |
Array
(
[id] => 5858960
[patent_doc_number] => 20060228798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Homologous recombination in multipotent adult progenitor cells'
[patent_app_type] => utility
[patent_app_number] => 10/536716
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20143
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10536716
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/536716 | Homologous recombination in multipotent adult progenitor cells | Nov 24, 2003 | Abandoned |
Array
(
[id] => 7269437
[patent_doc_number] => 20040057955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Methods of inhibition of stenosis and/or sclerosis of the aortic valve'
[patent_app_type] => new
[patent_app_number] => 10/398492
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8327
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20040057955.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398492
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398492 | Methods of inhibition of stenosis and/or sclerosis of the aortic valve | Nov 23, 2003 | Abandoned |
Array
(
[id] => 5119950
[patent_doc_number] => 20070141664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Csnks as modifiers of the rac pathway and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/535445
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15718
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141664.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535445
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535445 | Csnks as modifiers of the rac pathway and methods of use | Nov 23, 2003 | Abandoned |
Array
(
[id] => 7286797
[patent_doc_number] => 20040146907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Methods and compositions for detecting dysplasia'
[patent_app_type] => new
[patent_app_number] => 10/712124
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 115
[patent_figures_cnt] => 115
[patent_no_of_words] => 37763
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146907.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712124
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712124 | Methods and compositions for detecting dysplasia | Nov 12, 2003 | Abandoned |
Array
(
[id] => 4516408
[patent_doc_number] => 07932374
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-26
[patent_title] => 'Compositions and methods for the modification of gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/702319
[patent_app_country] => US
[patent_app_date] => 2003-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 10671
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/932/07932374.pdf
[firstpage_image] =>[orig_patent_app_number] => 10702319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/702319 | Compositions and methods for the modification of gene expression | Nov 5, 2003 | Issued |
Array
(
[id] => 5663318
[patent_doc_number] => 20060253914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Ha4,a new osteoblast-and chondrocyte-specific small secreted peptide, compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/534099
[patent_app_country] => US
[patent_app_date] => 2003-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 30619
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20060253914.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534099
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534099 | Ha4,a new osteoblast-and chondrocyte-specific small secreted peptide, compositions and methods of use | Nov 3, 2003 | Abandoned |
Array
(
[id] => 5851044
[patent_doc_number] => 20060234235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Methods and compositions for the diagnosis of neuroendocrine lung cancer'
[patent_app_type] => utility
[patent_app_number] => 10/533459
[patent_app_country] => US
[patent_app_date] => 2003-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 26452
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234235.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533459
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533459 | Methods and compositions for the diagnosis of neuroendocrine lung cancer | Nov 2, 2003 | Abandoned |
Array
(
[id] => 7176021
[patent_doc_number] => 20040078833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Mutations in and genomic structure of herg - along QT syndrome gene'
[patent_app_type] => new
[patent_app_number] => 10/696708
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 36740
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20040078833.pdf
[firstpage_image] =>[orig_patent_app_number] => 10696708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/696708 | Mutations in and genomic structure of HERG—a long QT syndrome gene | Oct 29, 2003 | Issued |
Array
(
[id] => 7364162
[patent_doc_number] => 20040091929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941'
[patent_app_type] => new
[patent_app_number] => 10/696706
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 40329
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10696706
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/696706 | Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 | Oct 28, 2003 | Abandoned |